Skip to search formSkip to main contentSkip to account menu

ASM-024

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of β2-Adrenoreceptor Desensitized Tracheas
Inhaled β2-adrenoreceptor agonists are widely used in asthma and chronic obstructive pulmonary disease (COPD) for… 
2011
2011
Characterization Of The Pharmacokinetic And Safety Profile Of ASM-024, A Novel Nicotinic Agonist Being Developed For Asthma, Following Inhalation In Human Subjects
2010
2010
Metabolism of ASM-024, a Novel Nicotinic Agonist Being Developed for the Treatment of Asthma
P1172) BACKGROUND: Nicotinic acetylcholine receptors are expressed on immune and structural cells and associated with… 
2010
2010
A phase I Inhalation Study on ASM-024, a Novel Nicotinic Agonist Being Developed for the Treatment of Asthma
P1175) Background: ASM-024 is a small synthetic agonist of the nicotinic acetylcholine receptor that displays both anti… 
2010
2010
Dual In Vitro Anti-inflammatory And Ex-vivo Smooth Muscle Relaxing Properties Of ASM-024, A Nicotinic Receptor Agonist
2010
2010
ASM-024, A Nicotinic Receptor Agonist, Decreases Lung Inflammation And Airway Hyperresponsiveness In A Mouse Model Of Asthma
2010
2010
Targeting Nicotinic Acetylcholine Receptors To Treat Asthma: Pharmacokinetics And Metabolism Of ASM-024, A New Nicotinic Receptor Agonist
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)